DSIP (Delta Sleep Inducing Peptide) is an experimental neuropeptide being studied in the laboratory for its potential role in regulating circadian rhythms, neurological recovery, and neuroendocrine balance.
Primarily used in research to explore mechanisms related to sleep, cellular stress, and physiological recovery.
Composition
DSIP — 5 mg per vial (lyophilized form)
Experimental exhibition
• Quantities studied: 100–500 mcg in preclinical research
• Exploration of neuroendocrine pathways
• Analysis of circadian regulation
• Studies conducted in controlled environments
Informative benefits
• Designed for modulating sleep-wake cycles
• Research on neurological recovery
• Observation of hormonal regulation
• Exploration of the management of physiological stress
• Analysis of cellular recovery mechanisms
For research use only – Not intended for human consumption.